IRF3 and Familial prostate cancer: To explore the mechanism involved in siRNA-induced toxicity on the two human prostate cancer cell lines, we studied the signaling pathway involving TLR3-mediated activation of interferon regulatory factor 3 (IRF3), which leads to release of IFNβ and generation of an inflammatory response [40].